Neurocrine Biosciences Stock Forecast

Buy or Hold candidate since May 05, 2026 Gain 30.14%

The Neurocrine Biosciences stock price gained 0.93% on the last trading day (Friday, 24th Jul 2026), rising from $174.15 to $175.77. During the last trading day the stock fluctuated 2.23% from a day low at $173.43 to a day high of $177.30. The price has been going up and down for this period, and there has been a -0.76% loss for the last 2 weeks. Volume fell on the last day by -117 thousand shares and in total, 986 thousand shares were bought and sold for approximately $173.27 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 26.63% during the next 3 months and, with a 90% probability hold a price between $211.51 and $237.65 at the end of this 3-month period.

NBIX Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -2.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The Neurocrine Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $173.87 and $168.61. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Neurocrine Biosciences stock

Neurocrine Biosciences finds support from accumulated volume at $174.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $3.87 (2.23%) between high and low. For the last week, the stock has had daily average volatility of 2.91%.

Our recommended stop-loss: $168.85 (-3.94%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (NBIX) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Neurocrine Biosciences to open at $175.50, and during the day (based on 14 day Average True Range), to move between $173.39 and $178.15, which gives a possible trading interval of +/-$4.75 (+/-2.74%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 2.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $174.10 (0.95%) than the resistance at $178.24 (1.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Neurocrine Biosciences stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Neurocrine Biosciences stock to perform well in the short-term.

Current score: 2.033 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $175.50 ( 0.154%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk